Clinical trial
A Multicentric Validation Study on the Effectiveness and Safety of Artificial Intelligence Assisted System in Clinical Application of Retrograde Cholangiopancreatography
NCT04719117 is registered in ClinicalTrials.gov with Renmin Hospital of Wuhan University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicentric Validation Study on the Effectiveness and Safety of Artificial Intelligence Assisted System in Clinical Application of Retrograde Cholangiopancreatography
- Lead sponsor
- Renmin Hospital of Wuhan University
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- September 1, 2020
- Completion date
- December 31, 2021
- Enrollment
- 150 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
artificial intelligence, cholangiopancreatography, endoscopic retrograde, endoscopy, gastrointestinal disease